Profil
David P.
Nowotnik is currently a Director at TheraTarget, Inc. He was previously a Senior Director-Product Development at Guilford Pharmaceuticals, Inc. from 1994 to 1998.
He also held the position of Senior Vice President-Research & Development at Abeona Therapeutics, Inc. Dr. Nowotnik earned a doctorate degree from the University of London.
Aktive Positionen von David P. Nowotnik
| Unternehmen | Position | Beginn |
|---|---|---|
TheraTarget, Inc.
TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical drug delivery company which develops polymer-drug conjugates | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von David P. Nowotnik
| Unternehmen | Position | Ende |
|---|---|---|
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Corporate Officer/Principal | 01.01.1998 |
| ABEONA THERAPEUTICS INC. | Corporate Officer/Principal | - |
Ausbildung von David P. Nowotnik
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Abeona Therapeutics, Inc.
Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TheraTarget, Inc.
TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical drug delivery company which develops polymer-drug conjugates | Health Technology |
















